Wednesday, March 26, 2008 5:04:56 AM
...WE AWAIT "SAFETY" DATA...
Dew, Iwfal, Qdot & Exwannabe...
""I can think of two prominent drugs that had a long sequence of zeros to the right of the decimal point in their phase-3 p-values and YET ALMOST DIDN'T MAKE IT TO MARKET.""
,,,HOWEVER THEY DID MAKE IT TO MARKET. Spewing FUD again Dewmeister,,,where is the rest of the story and facts?,,,You're first "at least six "slam dunk"" FUD was more entertaining .
(Actually reads Dew concedes Proellex makes it to market.)
Now throw in the other boys "FRAUD", SPA,IND, PH 1/2/3'S, Overseas trials and other FUD and what do we have?...
FUD, FUD & FUD.
...WE AWAIT THE "SAFETY" DATA...
Thanks for Dewophile and AKA's responses.
http://investorshub.advfn.com/boards/read_msg.asp?message_id=27859847
http://investorshub.advfn.com/boards/read_msg.asp?message_id=27917585
good luck to all
p.s.
I'm flying out to the Gobi Desert to oversee the Proellex Overseas trials.
Dew, Iwfal, Qdot & Exwannabe...
""I can think of two prominent drugs that had a long sequence of zeros to the right of the decimal point in their phase-3 p-values and YET ALMOST DIDN'T MAKE IT TO MARKET.""
,,,HOWEVER THEY DID MAKE IT TO MARKET. Spewing FUD again Dewmeister,,,where is the rest of the story and facts?,,,You're first "at least six "slam dunk"" FUD was more entertaining .
(Actually reads Dew concedes Proellex makes it to market.)
Now throw in the other boys "FRAUD", SPA,IND, PH 1/2/3'S, Overseas trials and other FUD and what do we have?...
FUD, FUD & FUD.
...WE AWAIT THE "SAFETY" DATA...
Thanks for Dewophile and AKA's responses.
http://investorshub.advfn.com/boards/read_msg.asp?message_id=27859847
http://investorshub.advfn.com/boards/read_msg.asp?message_id=27917585
good luck to all
p.s.
I'm flying out to the Gobi Desert to oversee the Proellex Overseas trials.
Recent RPRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2026 08:48:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 08:01:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/26/2026 09:49:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 01:20:12 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/20/2026 08:23:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:38:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2026 09:22:49 PM
- Form 13F-NT - Quarterly report filed by institutional managers, Notice • Edgar (US Regulatory) • 05/14/2026 06:29:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:14:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:12:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:10:50 PM
- Royalty Pharma to present at upcoming investor conferences • GlobeNewswire Inc. • 05/07/2026 08:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 01:04:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:31:54 AM
- Royalty Pharma reports first quarter 2026 results • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/30/2026 09:54:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/28/2026 09:00:16 PM
- Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation • GlobeNewswire Inc. • 04/21/2026 05:00:00 PM
- Royalty Pharma Declares Second Quarter 2026 Dividend • GlobeNewswire Inc. • 04/17/2026 12:30:00 PM
- Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 • GlobeNewswire Inc. • 04/15/2026 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 01:53:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/10/2026 08:11:03 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 08:10:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:58:57 PM
